Search clinical trials for: Hectorol (doxercalciferol capsules), 0.5mcg

Total 37 results

Genzyme, a Sanofi Company

Completed

A Phase 4, Conversion Study of Hectorol® Injection to Hectorol® Capsules in Stage 5 CKD Patients on Dialysis

Secondary Hyperparathyroidism

United States
Genzyme, a Sanofi Company

Completed

Study of Safety and Efficacy of Doxercalciferol in Patients With Chronic Kidney Disease, Stage 3 or 4, and Secondary Hyperparathyroidism

Renal Failure | Secondary Hyperparathyroidism | Chronic Renal Insufficiency

United States, Puerto Rico
Genzyme, a Sanofi Company

Completed

A Phase 4 Study to Determine Dosing of Hectorol® Capsules When Converting From Zemplar® Injection

Secondary Hyperparathyroidism

United States
Yung Shin Pharm. Ind. Co., Ltd.
Changhua Christian Hospital

Completed

A Study to Evaluate the Effects of RCN3028 on Moderate to Severe Vasomotor Symptoms in Women (RDC)

Hot Flashes | PMS

Taiwan
Hanmi Pharmaceutical Company Limited

Completed

A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HCP1303 Capsules

Benign Prostatic Hyperplasia
Emory University

Terminated

Mineral Metabolism and Vascular Effects of Vitamin D Therapy in Kidney Transplant Patients (PAD)

Hyperparathyroidism, Secondary

United States
Genzyme, a Sanofi Company

Completed

A Study to Evaluate the Safety and Effectiveness of Doxercalciferol Capsules in Participants With Moderate to Severe Psoriasis

Moderate to Severe Chronic Plaque Psoriasis

United States
OPKO IP Holdings II, Inc.

Completed

Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT)

Chronic Kidney Disease | Secondary Hyperparathyroidism | Chronic Renal Failure | Chronic Renal Insufficiency

United States
Mariana Markell
Genzyme, a Sanofi Company

Completed

Pilot Study Evaluating Doxercalciferol Replacement Therapy in Kidney Transplant Recipients

Chronic Kidney Disease | Kidney Transplantation

United States
Genzyme, a Sanofi Company

Completed

A Phase 4 Pharmacokinetic Study of Hectorol Injection and Zemplar Injection in CKD Subjects on Hemodialysis

Secondary Hyperparathyroidism

United States
HK inno.N Corporation

Completed

Bioequivalence and Safety Study of IN-A012 and Akynzeo Capsules in Male and Female Healthy Korean Subjects

Healthy

Korea, Republic of
University of Wisconsin, Madison
National Cancer Institute (NCI)

Completed

Doxercalciferol in Treating Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

Myelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative Diseases

United States
Indiana University School of Medicine

Completed

Cholecalciferol Versus Doxercalciferol in the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease

Renal Osteodystrophy

United States
Sanofi

Active, not recruiting

Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary Hyperparathyroidism Not Yet on Dialysis

Secondary Hyperparathyroidism-Chronic Kidney Disease

United States, Chile
GlaxoSmithKline

Completed

A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East Asia

Prostatic Hyperplasia

Australia
Hanmi Pharmaceutical Company Limited

Completed

A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPH

Benign Prostate Hyperplasia

Korea, Republic of
GlaxoSmithKline

Completed

Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulosin Monotherapy, in Men With Moderate to Severe Benign Prostatic Hyperplasia

Prostatic Hyperplasia

Korea, Republic of, China, Japan, Taiwan
GlaxoSmithKline

Completed

Bioavailability of Two Combination Products of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) in Asian Males. (ARI115707)

Prostatic Hyperplasia

Australia
OPKO Health, Inc.

Completed

Extension Study of CTAP101-CL-3001 or CTAP101-CL-3002

Vitamin D Deficiency | Chronic Kidney Disease | Hyperparathyroidism, Secondary
University of Wisconsin, Madison
Sanofi; Genzyme, a Sanofi Company

Terminated

Study of Docetaxel With Doxercalciferol or Placebo for Advanced Prostate Cancer

Prostate Cancer

United States
Eunice Kennedy Shriver National Institute of Child...
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...

Completed

Effects of Colchicine in Non-Diabetic Adults With Metabolic Syndrome

Obesity | Metabolic Disease

United States
National Institute of Diabetes and Digestive and...

Completed

Regulation of Bone Formation in Renal Osteodystrophy

Secondary Hyperparathyroidism | Renal Osteodystrophy
GlaxoSmithKline

Completed

Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH)

Prostatic Hyperplasia | Benign Prostatic Hyperplasia

China
Addpharma Inc.

Completed

To Evaluate the Pharmacokinetics and Safety of AD-208

Androgenetic Alopecia

Korea, Republic of
Ain Shams University

Completed

Duloxetine and Dexamethasone for Improving Postoperative Pain

Post Operative Pain Control
Alvogen Korea

Completed

Phase IV Study of Qsymia in Obese Patients

Obesity

Korea, Republic of
Creighton University
Dialysis Clinic, Inc.

Completed

Vitamin D Effect on Calcium Absorption on Persons on Hemodialysis (NEPH-Cal-D)

Vitamin D Deficiency | End Stage Renal Disease | Chronic Kidney Disease

United States
Bangabandhu Sheikh Mujib Medical University, Dhaka...

Completed

Effect of Vitamin D3 on Lung Function and Exercise Tolerance in COPD Patients

Stable COPD Patients

Bangladesh
The Cleveland Clinic

Active, not recruiting

Preoperative Tamsulosin to Prevent Postoperative Urinary Retention After Surgery For Pelvic Floor Disorders

Urinary Retention

United States
Korea University Anam Hospital
GL Pharm Tech Corporation

Completed

PK Comparison of GL2701 With Finasteride and Tamsulosin in Combination

Benign Prostatic Hyperplasia (BPH)

Korea, Republic of
Nottingham University Hospitals NHS Trust

Active, not recruiting

REpurposing SirolimUS in Compensated Advanced Chronic Liver Disease. The RESUS Proof of Concept Study (RESUS)

Advanced Chronic Liver Disease

United Kingdom
Helsinn Healthcare SA

Active, not recruiting

Oral Akynzeo® vs Standard of Care in Preventing CINV in High-risk MEC Patients (MyRisk) (CINV)

Chemotherapy-induced Nausea and Vomiting

Spain, Germany, Switzerland, China, Czechia, United Kingdom, Greece
University of California, Irvine

Enrolling by invitation

Trial of Tadalafil, Tamsulosin and Combination for Access Sheath Deployment

Nephrolithiasis

United States
Jeffrey L Gum MD

Enrolling by invitation

Dronabinol for Post-operative Pain After Lumbar Fusion

Post-operative Pain

United States
The George Institute
University of Sydney

Terminated

Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT) Cognitive Sub-Study (TRIDENT COG)

Hypertension | Cerebral Small Vessel Diseases | Dementia, Vascular | Stroke Hemorrhagic | Cognitive Decline | Intracerebral Hemorrhage

Australia, Netherlands
The George Institute
University of Sydney

Terminated

Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial Magnetic Resonance Imaging Sub-study (TRIDENT-MRI)

Stroke | Hypertension | Cerebral Small Vessel Diseases | Vascular Dementia | Intracerebral Hemorrhage

Australia
Mansoura University

Not yet recruiting

Progestin-primed Ovarian Stimulation Protocol Versus GnRH Antagonist Protocol in Polycystic Ovary Syndrome Patients Undergoing IVF/ICSI Cycles

PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries

Search clinical trials for: Hectorol (doxercalciferol capsules), 0.5mcg

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burundi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations